News
1d
GlobalData on MSNNSW eases access to ADHD medication resupplyIndividuals in NSW will have the option to receive their ADHD medication resupply from their regular doctor for the first ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
9d
Verywell Health on MSNWhen ADHD Medication Side Effects Get in the Way—and What You Can DoMedications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...
When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...
A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...
3d
HealthDay on MSNADHD Medications Remain Linked to Lower Risk for Real-World Adverse OutcomesAttention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...
A new study found that exposure to misinformation about ADHD on the platform reduced students’ factual knowledge but ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
4don MSN
New Zealanders with attention-deficit hyperactivity disorder (ADHD) will now have easier access to diagnosis and medication ...
The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results